<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">28535396</PMID><DateCompleted><Year>2017</Year><Month>08</Month><Day>25</Day></DateCompleted><DateRevised><Year>2022</Year><Month>09</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1678-4391</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>4</Issue><PubDate><Year>2017</Year><Season>Jul-Aug</Season></PubDate></JournalIssue><Title>The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases</Title><ISOAbbreviation>Braz J Infect Dis</ISOAbbreviation></Journal><ArticleTitle>Molecular identification of viral agents associated with acute conjunctivitis: a prospective controlled study.</ArticleTitle><Pagination><StartPage>391</StartPage><EndPage>395</EndPage><MedlinePgn>391-395</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bjid.2017.03.016</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1413-8670(16)30206-9</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Viral conjunctivitis are the most frequent infections in ophthalmology clinics. The diagnosis is usually relying on clinical findings and medical history. However, topical antibiotics are often used unnecessarily addition to symptomatic treatment because of unsure agents. We aimed to detect the Adenovirus, Coxsackievirus and Enterovirus from conjunctiva and pharyngeal samples of patients.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The conjunctiva and pharyngeal samples of the patients with conjunctivitis were taken by Virocult transport media and kept at -80&#x30a;C up to study day. Adenovirus spp, Enterovirus 70 and Enterovirus 71, Coxsackie A24 and Coxsackie A16 were detected by real-time PCR. Samples from healthy health care workers of ophthalmology clinic were used for control group.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 176 samples (conjunctival and pharyngeal samples of 62 patient and 26 healthy subjects) were included. The mean age of 34 (55.7%) male and 27 (44.3%) female patients was 34&#xb1;17. Twenty five (40.3%) of the patients were receiving antibiotic drops at first visit. The main etiologic agent in conjunctival samples was found to be Adenovirus (46/62, 74.2%) followed by Enterovirus 70 (4/62, 6.4%) and Enterovirus 71 (4/62, 6.4%). Coxsackievirus 16 and 24 were also found in 2 patients (1/62 each, 1.6%). Pharyngeal samples were also positive for Adenovirus (20/62, 32.3%), Enterovirus 70 and 71 (7/62, 11.3% and 5/62, 8.1% respectively), Coxsackievirus 16 and 24 (2/62, 3.2% and 1/61, 1.6%).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">It is very difficult in viral conjunctivitis to make clinical differentiation caused by different agents because of common clinical signs and symptoms. In routine clinical work, the viral conjunctivitis usually related with Adenovirus. But almost one fourth of the patients' conjunctivitis were not related to Adenovirus, which shows the importance of the laboratory diagnostics. True diagnosis plays an important role on prevention of contamination and unnecessary use of antibiotics in viral conjunctivitis.</AbstractText><CopyrightInformation>Copyright &#xa9; 2017 Sociedade Brasileira de Infectologia. Published by Elsevier Editora Ltda. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ak&#xe7;ay</LastName><ForeName>Emine</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Y&#x131;ld&#x131;r&#x131;m Beyaz&#x131;t, University Faculty of Medicine, Department of Ophthalmology, Ankara, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>&#xc7;arhan</LastName><ForeName>Ahmet</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Y&#x131;ld&#x131;r&#x131;m Beyaz&#x131;t, University Faculty of Medicine, Department of Medical Biology, Ankara, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hondur</LastName><ForeName>G&#xf6;zde</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Ulucanlar Eye Training and Research Hospital, Ankara, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tufan</LastName><ForeName>Zeliha Ko&#xe7;ak</ForeName><Initials>ZK</Initials><AffiliationInfo><Affiliation>Y&#x131;ld&#x131;r&#x131;m Beyaz&#x131;t University, Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology, Ankara, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duru</LastName><ForeName>Necati</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Kayseri Education and Research Hospital, Ophthalmology Clinic, Kayseri, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>K&#x131;l&#x131;&#xe7;</LastName><ForeName>Sel&#xe7;uk</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Turkey Public Health Institute, Ankara, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ensari</LastName><ForeName>Ezgi Naz</ForeName><Initials>EN</Initials><AffiliationInfo><Affiliation>Y&#x131;ld&#x131;r&#x131;m Beyaz&#x131;t, University Faculty of Medicine, Department of Ophthalmology, Ankara, Turkey. Electronic address: enazensari@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>U&#x11f;urlu</LastName><ForeName>Nagihan</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Y&#x131;ld&#x131;r&#x131;m Beyaz&#x131;t, University Faculty of Medicine, Department of Ophthalmology, Ankara, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>&#xc7;a&#x11f;&#x131;l</LastName><ForeName>Nurullah</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Y&#x131;ld&#x131;r&#x131;m Beyaz&#x131;t, University Faculty of Medicine, Department of Ophthalmology, Ankara, Turkey.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D018848">Controlled Clinical Trial</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>05</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>Brazil</Country><MedlineTA>Braz J Infect Dis</MedlineTA><NlmUniqueID>9812937</NlmUniqueID><ISSNLinking>1413-8670</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004279">DNA, Viral</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000208" MajorTopicYN="N">Acute Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000256" MajorTopicYN="N">Adenoviridae</DescriptorName><QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000302" MajorTopicYN="Y">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003236" MajorTopicYN="N">Conjunctivitis, Viral</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004279" MajorTopicYN="N">DNA, Viral</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="Y">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="N">Enterovirus</DescriptorName><QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000302" MajorTopicYN="Y">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010614" MajorTopicYN="N">Pharynx</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016133" MajorTopicYN="N">Polymerase Chain Reaction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Adenovirus</Keyword><Keyword MajorTopicYN="N">Conjunctivitis</Keyword><Keyword MajorTopicYN="N">PCR</Keyword><Keyword MajorTopicYN="N">Viral</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>10</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>1</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>3</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>5</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>8</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>5</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2017</Year><Month>5</Month><Day>20</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28535396</ArticleId><ArticleId IdType="pmc">PMC9427797</ArticleId><ArticleId IdType="doi">10.1016/j.bjid.2017.03.016</ArticleId><ArticleId IdType="pii">S1413-8670(16)30206-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Uchio E., Takeuchi S., Itoh N., et al. Clinical and epidemiological features of acute follicular conjunctivitis with special reference to that caused by herpes simplex virus type 1. Br J Ophthalmol. 2000;84:968&#x2013;972.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1723617</ArticleId><ArticleId IdType="pubmed">10966946</ArticleId></ArticleIdList></Reference><Reference><Citation>Woodland R.M., Darougar S., Thaker U., et al. Causes of conjunctivitis and keratoconjunctivitis in Karachi, Pakistan. Trans R Soc Trop Med Hyg. 1992;86:317&#x2013;320.</Citation><ArticleIdList><ArticleId IdType="pubmed">1412664</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Brien T.P., Jeng B.H., McDonald M., Raizman M.B. Acute conjunctivitis: truth and misconceptions. Curr Med Res Opin. 2009;25:1953&#x2013;1961.</Citation><ArticleIdList><ArticleId IdType="pubmed">19552618</ArticleId></ArticleIdList></Reference><Reference><Citation>Lynch J.P., Kajon E.A. Adenovirus: epidemiology, global spread of novel serotypes, and advances in treatment and prevention. Semin Respir Crit Care Med. 2016;37:586&#x2013;602.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7171713</ArticleId><ArticleId IdType="pubmed">27486739</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J., Yang Y., Lin C., et al. Etiology of acute conjunctivitis due to coxsackievirus A24 variant, human adenovirus, herpes simplex virus, and chlamydia in Beijing, China. Jpn J Infect Dis. 2014;67:349&#x2013;355.</Citation><ArticleIdList><ArticleId IdType="pubmed">25241684</ArticleId></ArticleIdList></Reference><Reference><Citation>American Academy of Ophthalmology . American Academy of Ophthalmology; San Francisco, CA: 2011. Cornea/external disease panel. Preferred practice pattern guidelines: conjunctivitis-limited revision.</Citation></Reference><Reference><Citation>Stenson S., Newman R., Fedukowicz H. Laboratory studies in acute conjunctivitis. Arch Ophthalmol. 1982;100:1275&#x2013;1277.</Citation><ArticleIdList><ArticleId IdType="pubmed">7049134</ArticleId></ArticleIdList></Reference><Reference><Citation>Fitch C.P., Rapoza P.A., Owens S., et al. Epidemiology and diagnosis of acute conjunctivitis at an inner-city hospital. Ophthalmology. 1989;96:1215&#x2013;1220.</Citation><ArticleIdList><ArticleId IdType="pubmed">2797725</ArticleId></ArticleIdList></Reference><Reference><Citation>Warren D., Nelson K.E., Farrar J.A., et al. A large outbreak of epidemic keratoconjunctivitis: problems in controlling nosocomial spread. J Infect Dis. 1989;160:938&#x2013;943.</Citation><ArticleIdList><ArticleId IdType="pubmed">2555421</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinto R.D.P., Lira R.P.C., Arieta C.E.L., Castro R.S., Bonon S.H.A. Prevalence of adenoviral conjunctivitis. Clinics. 2015;70:748&#x2013;750.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4642493</ArticleId><ArticleId IdType="pubmed">26602522</ArticleId></ArticleIdList></Reference><Reference><Citation>Marangon F.B., Miller D., Alfonso E. Laboratory results in ocular viral diseases: implications in clinical-laboratory correlation. Arq Bras Oftalmol. 2007;70:189&#x2013;194.</Citation><ArticleIdList><ArticleId IdType="pubmed">17589685</ArticleId></ArticleIdList></Reference><Reference><Citation>Cronau H., Kankanala R.R., Mauger T. Diagnosis and management of red eye in primary care. Am Fam Physician. 2010;81:137&#x2013;144.</Citation><ArticleIdList><ArticleId IdType="pubmed">20082509</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaufman H.E. Adenovirus advances: new diagnostic and therapeutic options. Curr Opin Ophthalmol. 2011;22:290&#x2013;293.</Citation><ArticleIdList><ArticleId IdType="pubmed">21537185</ArticleId></ArticleIdList></Reference><Reference><Citation>1st ed. Kathmandu Nepal Ministry of Health; Nepal: 1997. Nepalese National Formulary.</Citation></Reference><Reference><Citation>Asbell P.A., Colby K.A., Deng S., et al. OcularTRUST: nationwide antimicrobial susceptibility patterns in ocular isolates. Am J Ophthalmol. 2008;145:951&#x2013;958.</Citation><ArticleIdList><ArticleId IdType="pubmed">18374299</ArticleId></ArticleIdList></Reference><Reference><Citation>Sood A.K., Gupta A., Dabral T. Indiscriminate use of topical antibiotics: a menace. Indian J Ophthalmol. 1999;47:121&#x2013;124.</Citation></Reference><Reference><Citation>Gaynes B.I., Fiscella R. Topical nonsteroidal anti-inflammatory drugs for ophthalmic use: a safety review. Drug Saf. 2002;25:233&#x2013;250.</Citation><ArticleIdList><ArticleId IdType="pubmed">11994027</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurna A.S., Altun A., Oflaz A., Karatay A.A. Evaluation of the impact of persistent subepithelial corneal infiltrations on the visual performance and corneal optical quality after epidemic keratoconjunctivitis. Acta Ophthalmol. 2015;93:377&#x2013;382.</Citation><ArticleIdList><ArticleId IdType="pubmed">25043311</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>